EGFR ligands drive multipotential stromal cells to produce multiple growth factors and cytokines via early growth response-1

Stem Cells and Development

Volumn 21, Issue 13, 2012, Pages 2541-2551

  Kerpedjieva, Svetoslava S ^a   Kim, Duk Soo ^a   Barbeau, Dominique J ^a   Tamama, Kenichi ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DIPHTHERIA TOXOID CRM197; EARLY GROWTH RESPONSE FACTOR 1; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; SHORT HAIRPIN RNA;

ARTICLE; GENE EXPRESSION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MICROARRAY ANALYSIS; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; STROMA CELL; UPREGULATION;

AUTOCRINE COMMUNICATION; CELL LINE, TUMOR; EARLY GROWTH RESPONSE PROTEIN 1; FIBROBLASTS; GENE KNOCKDOWN TECHNIQUES; GLYCOPROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-6; LIGANDS; MAP KINASE SIGNALING SYSTEM; MESENCHYMAL STROMAL CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARACRINE COMMUNICATION; PROTEIN KINASE C; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, SMALL INTERFERING; TETRADECANOYLPHORBOL ACETATE;

EID: 84865702882     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2011.0711     Document Type: Article

References (46)

1. Tamama K, D Kim and SS Kerpedjieva. Molecular mechanisms of hypoxia-mediated enhanced in vitro expansion, augmented self-renewal, and increased therapeutic potential of mesenchymal stem cells. In: Hypoxia: Causes, Types and Management. Vordermark D, ed. Nova Science Publishers, Inc., Hauppauge, NY (In press).
2. Tamama K, H Kawasaki, SS Kerpedjieva, J Guan, RK Ganju and CK Sen. (2011). Differential roles of hypoxia inducible factor subunits in multipotential stromal cells under hypoxic condition. J Cell Biochem 112:804-817.
3. Huss R. (2010). Stem cell therapeutics: Hope for patients and biopharma! Stem Cells Dev 19:593-594.
4. Spencer ND, JM Gimble and MJ Lopez. (2011). Mesenchymal stromal cells: past, present, and future. Vet Surg 40:129-139.
5. Barry FP and JM Murphy. (2004). Mesenchymal stem cells: Clinical applications and biological characterization. Int J Biochem Cell Biol 36:568-584.
6. Phinney DG and DJ Prockop. (2007). Concise review: Mesenchymal stem/multipotent stromal cells: The state of transdifferentiation and modes of tissue repair -current views. Stem Cells 25:2896-2902.
7. Tamama K, VH Fan, LG Griffith, HC Blair and A Wells. (2006). Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells. Stem Cells 24:686-695.
8. Prockop DJ. (1997). Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71-74.
9. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
10. Owen M and AJ Friedenstein. (1988). Stromal stem cells: Marrow-derived osteogenic precursors. Ciba Found Symp 136:42-60.
11. Kinnaird T, E Stabile, MS Burnett and SE Epstein. (2004). Bone marrow-derived cells for enhancing collateral development: Mechanisms, animal data, and initial clinical experiences. Circ Res 95:354-363.
12. Friedenstein AJ, JF Gorskaja and NN Kulagina. (1976). Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 4:267-274.
13. Oswald J, S Boxberger, B Jorgensen, S Feldmann, G Ehninger, M Bornhauser and C Werner. (2004). Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 22:377-384.
14. Tamama K, CK Sen and A Wells. (2008). Differentiation of bone marrow mesenchymal stem cells into the smooth muscle lineage by blocking ERK/MAPK signaling pathway. Stem Cells Dev 17:897-908.
15. Caplan AI. (2009). Why are MSCs therapeutic? New data: new insight. J Pathol 217:318-324.
16. Salgado AJ, RL Reis, NJ Sousa and JM Gimble. (2010). Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine. Curr Stem Cell Res Ther 5:103-110.
17. Chen L, EE Tredget, PY Wu and Y Wu. (2008). Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 3:e1886.
18. Kinnaird T, E Stabile, MS Burnett, CW Lee, S Barr, S Fuchs and SE Epstein. (2004). Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94:678-685.
19. Kinnaird T, E Stabile, MS Burnett, M Shou, CW Lee, S Barr, S Fuchs and SE Epstein. (2004). Local delivery of marrowderived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109:1543-1549.
20. Silverman ES and T Collins. (1999). Pathways of Egr-1-mediated gene transcription in vascular biology.AmJ Pathol 154:665-670.
21. Thiel G and G Cibelli. (2002). Regulation of life and death by the zinc finger transcription factor Egr-1. J Cell Physiol 193:287-292.
22. De Luca A, M Gallo, D Aldinucci, D Ribatti, L Lamura, A D'Alessio, R De Filippi, A Pinto and N Normanno. (2011). Role of the EGFR ligand/receptor system in the secretion of angiogenic factors in mesenchymal stem cells. J Cell Physiol 226:2131-2138.
23. Tamama K, H Kawasaki and A Wells. (2010). Epidermal growth factor (EGF) treatment on multipotential stromal cells (MSCs). Possible enhancement of therapeutic potential of MSC. J Biomed Biotechnol 2010:795385.
24. Wang Y, PR Crisostomo, M Wang, TA Markel, NM Novotny and DR Meldrum. (2008). TGF-Alpha increases human mesenchymal stem cell-secreted VEGF by MEK-And PI3-Kbut not JNK-or ERK-dependent mechanisms. Am J Physiol Regul Integr Comp Physiol 295:R1115-R1123.
25. Herrmann JL, AM Abarbanell, BR Weil, Y Wang, JA Poynter, MC Manukyan and DR Meldrum. (2010). Postinfarct intramyocardial injection of mesenchymal stem cells pretreated with TGF-Alpha improves acute myocardial function. Am J Physiol Regul Integr Comp Physiol 299:R371-R378.
26. Herrmann JL, YWang,AMAbarbanell, BRWeil, J Tan andDR Meldrum. (2010). Preconditioning mesenchymal stem cells with transforming growth factor-Alpha improves mesenchymal stem cell-mediated cardioprotection. Shock 33:24-30.
27. Okamoto T, T Aoyama, T Nakayama, T Nakamata, T Hosaka, K Nishijo, T Nakamura, T Kiyono and J Toguchida. (2002). Clonal heterogeneity in differentiation potential of immortalized human mesenchymal stem cells. Biochem Biophys Res Commun 295:354-361.
28. Kubo H, M Shimizu, Y Taya, T Kawamoto, M Michida, E Kaneko, A Igarashi, M Nishimura, K Segoshi, et al. (2009). Identification of mesenchymal stem cell (MSC)-Transcription factors by microarray and knockdown analyses, and signature molecule-marked MSC in bone marrow by immunohistochemistry. Genes Cells 14:407-424.
29. Kawahara K and A Shimazu. (2003). Expression and intracellular localization of progesterone receptors in cultured human gingival fibroblasts. J Periodontal Res 38:242-246.
30. ENCODE Project Consortium. (2004). The ENCODE (ENCyclopedia Of DNA Elements) Project. Science 306:636-640.
31. ENCODE Project Consortium. (2011). A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol 9:e1001046.
32. Yan SF, E Harja, M Andrassy, T Fujita and AM Schmidt. (2006). Protein kinase C beta/early growth response-1 pathway: A key player in ischemia, atherosclerosis, and restenosis. J Am Coll Cardiol 48:A47-A55.
33. Nishizuka Y. (1995). Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 9:484-496.
34. Wells A. (1999). EGF receptor. Int J Biochem Cell Biol 31:637-643.
35. Pricola KL, NZ Kuhn, H Haleem-Smith, Y Song and RS Tuan. (2009). Interleukin-6 maintains bone marrow-derived mesenchymal stem cell stemness by an ERK1/2-dependent mechanism. J Cell Biochem 108:577-588.
36. Uccelli A, L Moretta and V Pistoia. (2008). Mesenchymal stem cells in health and disease. Nat Rev Immunol 8:726-736.
37. Elenius K, S Paul, G Allison, J Sun and M Klagsbrun. (1997). Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J 16:1268-1278.
38. Krampera M, A Pasini, A Rigo, MT Scupoli, C Tecchio, G Malpeli, A Scarpa, F Dazzi, G Pizzolo and F Vinante. (2005). HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: Inducing cell expansion and reversibly preventing multilineage differentiation. Blood 106:59-66.
39. Cochet C, GN Gill, J Meisenhelder, JA Cooper and T Hunter. (1984). C-kinase phosphorylates the epidermal growth factor receptor and reduces its epidermal growth factor-stimulated tyrosine protein kinase activity. J Biol Chem 259:2553-2558.
40. Friedman B, AR Frackelton, Jr., AH Ross, JM Connors, H Fujiki, T Sugimura and MR Rosner. (1984). Tumor promoters block tyrosine-specific phosphorylation of the epidermal growth factor receptor. ProcNatlAcad SciUSA81:3034-3038.
41. Mitamura T, S Higashiyama, N Taniguchi, M Klagsbrun and E Mekada. (1995). Diphtheria toxin binds to the epidermal growth factor (EGF)-like domain of human heparin-binding EGF-like growth factor/diphtheria toxin receptor and inhibits specifically its mitogenic activity. J Biol Chem 270:1015-1019.
42. Tamama K and SS Kerpedjieva. Acceleration of wound healing by multiple growth factors and cytokines secreted from multipotential stromal cells/mesenchymal stem cells (MSCs). In: Wound Healing Society Year Book (WHSYB) -Advances in Wound Care. Sen CK, ed. Mary Ann Liebert, Inc., New Rochelle, NY (In press).
43. Chase LG, U Lakshmipathy, LA Solchaga, MS Rao and MC Vemuri. (2010). A novel serum-free medium for the expansion of human mesenchymal stem cells. Stem Cell Res Ther 1:8.
44. Wells A and U Marti. (2002). Signalling shortcuts: Cell-surface receptors in the nucleus? Nat Rev Mol Cell Biol 3:697-702.
45. Sakamoto KM and DA Frank. (2009). CREB in the pathophysiology of cancer: Implications for targeting transcription factors for cancer therapy. Clin Cancer Res 15:2583-2587.
46. Caplan AI and JE Dennis. (2006). Mesenchymal stem cells as trophic mediators. J Cell Biochem 98:1076-1084.